David Toung
Stock Analyst at Argus Research
(3.35)
# 938
Out of 4,876 analysts
120
Total ratings
62.11%
Success rate
9.89%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $408.28 | +15.12% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $309.11 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $12.29 | - | 2 | Mar 31, 2025 | |
| ELV Elevance Health | Reiterates: Hold | $405 | $381.49 | +6.27% | 1 | Jan 29, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $182.31 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $167.18 | -25.23% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $150.01 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $277.13 | +22.69% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $725.78 | -7.69% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $91.46 | +64.01% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $775.45 | +8.32% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $65.01 | +46.13% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $74.38 | +47.89% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $260.59 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.19 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $241.88 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $393.55 | -21.23% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $379.30 | -18.27% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $533.71 | -40.04% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $134.38 | +0.46% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $110.67 | -32.23% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $46.35 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $79.10 | +39.06% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $86.02 | +91.82% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.41 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $51.84 | +136.30% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $69.85 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $120.01 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $152.41 | +1.70% | 4 | Mar 27, 2020 |
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $408.28
Upside: +15.12%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $309.11
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $12.29
Upside: -
Elevance Health
Jan 29, 2025
Reiterates: Hold
Price Target: $405
Current: $381.49
Upside: +6.27%
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $182.31
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $167.18
Upside: -25.23%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $150.01
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $277.13
Upside: +22.69%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $725.78
Upside: -7.69%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $91.46
Upside: +64.01%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $775.45
Upside: +8.32%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $65.01
Upside: +46.13%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $74.38
Upside: +47.89%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $260.59
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $24.19
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $241.88
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $393.55
Upside: -21.23%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $379.30
Upside: -18.27%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $533.71
Upside: -40.04%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $134.38
Upside: +0.46%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $110.67
Upside: -32.23%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $46.35
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $79.10
Upside: +39.06%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $86.02
Upside: +91.82%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.41
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $51.84
Upside: +136.30%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $69.85
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $120.01
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $152.41
Upside: +1.70%